The key players of dysbiosis in Noma disease; A systematic review of etiological studies

被引:5
|
作者
Uzochukwu, Ifeanyi [1 ]
Moyes, David [1 ]
Proctor, Gordon [1 ]
Ide, Mark [1 ]
机构
[1] Kings Coll London, Fac Dent Oral & Craniofacial Sci, Ctr Host Microbiome Interact, London, England
来源
FRONTIERS IN ORAL HEALTH | 2023年 / 4卷
关键词
oral health; Noma; etiology; microbiome; microbiology; molecular biology; dysbiosis; GINGIVAL CREVICULAR FLUID; CANCRUM-ORIS; FUSOBACTERIUM-NUCLEATUM; MICROBIOME; IDENTIFICATION; PERIODONTITIS; PCR; PATHOGENS;
D O I
10.3389/froh.2023.1095858
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Noma is a rapidly progressing periodontal disease with up to 90% mortality in developing countries. Poor, immunocompromised and severely malnourished children (2 to 6 years old) are mostly affected by Noma. Prevention and effective management of Noma is hindered by the lack of sufficient cohesive studies on the microbial etiology of the disease. Research efforts have not provided a comprehensive unified story of the disease. Bridging the gap between existing studies gives an insight on the disease pathogenesis. This current systematic review of etiological studies focuses on the key players of dysbiosis in Noma disease. This review was performed in accordance with the Preferred Reporting Items for Systemic review and Meta-Analyses (PRISMA) statement. Web of Science, MEDLINE via PubMed, Cochrane Library, Scopus, and Science Direct were searched electronically for clinical trials which applied culture dependent or molecular techniques to identify oral microbiota from Noma patients. Trials which involved periodontal diseases except Noma were excluded. After screening 275 articles, 153 full-texts articles were assessed for eligibility of which eight full text articles were selected for data extraction and analysis. The results show that 308 samples from 169 Noma participants (6 months to 15 years old) have been used in clinical trials. There was some variance in the microbiome identified due to the use of 3 different types of samples (crevicular fluid, subgingival plaque, and swabbed pus) and the ambiguity of the stage or advancement of Noma in the studies. Other limitations of the studies included in this review were: the absence of age-matched controls in some studies; the constraints of colony morphology as a tool in distinguishing between virulent fusobacterium genus at the species level; the difficulty in culturing spirochaetes in the laboratory; the choice of primers in DNA amplification; and the selection of probe sets in gene sequencing. This systematic review highlights spirochaetes and P. intermedia as putative trigger organisms in Noma dysbiosis, shows that F. nucleatum promotes biofilms formation in late stages of the disease and suggests that future studies should be longitudinal, with high throughput genome sequencing techniques used with gingival plaque samples from early stages of Noma.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Dysbiosis of Oral Microbiome: A Key Player in Oral Carcinogenesis? A Critical Review
    Devaraja, K.
    Aggarwal, Sadhna
    BIOMEDICINES, 2025, 13 (02)
  • [2] Noma and Noma-like disease in HIV/AIDS patients, a comorbid interaction: A systematic review
    Prado-Calleros, Hector M.
    Castillo-Ventura, Bertha B.
    Jimenez-Escobar, Irma
    Ramirez-Hinojosa, Juan P.
    Lopez-Gomez, Antonio
    Garcia-de-la-Cruz, Miguel
    Dayan-Nurko, Mijal
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2018, 12 (02): : 89 - 96
  • [3] Antibiotic-induced gut dysbiosis and autoimmune disease: A systematic review of preclinical studies
    Gobbo, Marcela Mizuhira
    Bomfim, Marina Bocamino
    Alves, Wille Ygor
    Oliveira, Karen Cristina
    Corsetti, Patricia Paiva
    Almeida, Leonardo Augusto de
    AUTOIMMUNITY REVIEWS, 2022, 21 (09)
  • [4] Culture-independent studies on bacterial dysbiosis in oral and oropharyngeal squamous cell carcinoma: A systematic review
    Gopinath, Divya
    Menon, Rohit Kunnath
    Banerjee, Moinak
    Yuxiong, Richard Su
    Botelho, Michael George
    Johnson, Newell W.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 139 : 31 - 40
  • [5] Dysbiosis A Review Highlighting Obesity and Inflammatory Bowel Disease
    Kim, Adam
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 : S20 - S24
  • [6] A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis
    S. Du Preez
    M. Corbitt
    H. Cabanas
    N. Eaton
    D. Staines
    S. Marshall-Gradisnik
    Systematic Reviews, 7
  • [7] Exploring the role of gut microbiota dysbiosis in gout pathogenesis: a systematic review
    Shirvani-Rad, Salman
    Khatibzade-Nasari, Niloufar
    Ejtahed, Hanieh-Sadat
    Larijani, Bagher
    FRONTIERS IN MEDICINE, 2023, 10
  • [8] A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis
    Du Preez, S.
    Corbitt, M.
    Cabanas, H.
    Eaton, N.
    Staines, D.
    Marshall-Gradisnik, S.
    SYSTEMATIC REVIEWS, 2018, 7
  • [9] Lower gastrointestinal tract dysbiosis in persistent critical illness: a systematic review
    Tang, Emily
    Doan, Nicholas
    Evans, Tess
    Litton, Edward
    JOURNAL OF MEDICAL MICROBIOLOGY, 2024, 73 (10)
  • [10] Oral dysbiosis and risk of gastrointestinal cancers: A systematic review and meta-analysis of longitudinal studies
    Madugula, Sowndarya
    Dhamodhar, Dinesh
    Prabu, D.
    Sindhu, R.
    Rajmohan, M.
    Sathiyapriya, S.
    Devdoss, Premkumar
    Jayaraman, Yuvaraj
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2024, 43 (04) : 729 - 739